Nostrum Life Sciences Ltd - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 07337803 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2018

FOR

NOSTRUM LIFE SCIENCES LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Dr P Madan

REGISTERED OFFICE:

151, Greenway

Pinner

Middlesex

HA5 3SL

REGISTERED NUMBER:

07337803 (England and Wales)

ACCOUNTANTS:

Macalvins Limited

Chartered Accountants

7 St John's Road

Harrow

Middlesex

HA1 2EY

CURRENT ASSETS

Stocks

4

8,315

6,120

Debtors

5

-

20,761

Cash at bank and in hand

8,160

25,938

16,475

52,819

CREDITORS

Amounts falling due within one year

6

25,231

47,055

NET CURRENT (LIABILITIES)/ASSETS

(8,756

)

5,764

TOTAL ASSETS LESS CURRENT LIABILITIES

(8,756

)

5,764

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

(8,856

)

5,664

SHAREHOLDERS' FUNDS

(8,756

)

5,764

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 February 2021 and were signed by:

N Chudasama - Director

1.	STATUTORY INFORMATION

Nostrum Life Sciences Ltd is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Changes in accounting policies

These financial statements for the year ended 31 August 2017 are the first financial statements that comply with

FRS 102 Section 1A small entities.The date of transition is 1 September 2015.

The transition to FRS 102 Section 1A small entities have resulted in no changes in accounting policies to those

used previously, therefore no separate statements for any adjustments are disclosed.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Going concern

Where total liabilities exceed current assets the directors consider the ability of the company to continue to meet

its liabilities from liquid assets as and when the liabilities fall due. The directors also consider the support given

to the company by its creditors. If the directors are satisfied that the company can meet its liabilities as and when

they fall due and that the company has sufficient support from its creditors, the accounts are prepared on a going

concern basis.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2017 - 2 ) .

4.

STOCKS

2018

2017

£

£

Finished goods

8,315

6,120

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2018

2017

£

£

Trade debtors

-

20,761

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2018

2017

£

£

Trade creditors

-

12,467

Director's current account

23,131

33,088

Accrued expenses

2,100

1,500

25,231

47,055